(Q36245164)

13 August 2017

1 reference

title

Cardiorenal disease: a clinical intersection (English)

1 reference

13 August 2017

Vikram Kalra

1

1 reference

13 August 2017

Sandeep Mahajan

series ordinal

2

1 reference

13 August 2017

Sanjay Kumar Agarwal

series ordinal

3

1 reference

13 August 2017

Suresh Chander Tiwari

series ordinal

4

1 reference

13 August 2017

publication date

1 January 2005

1 reference

International Urology and Nephrology

13 August 2017

published in

1 reference

13 August 2017

volume

37

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

175-184

1 reference

Weight gain continues in the 1990s: 10-year trends in weight and overweight from the CARDIA study. Coronary Artery Risk Development in Young Adults

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11255-004-1561-2

Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-004-1561-2

Renal function, neurohormonal activation, and survival in patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-004-1561-2

Diabetes, hypertension, and cardiovascular disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-004-1561-2

Chronic renal failure in non-insulin-dependent diabetes mellitus. A population-based study in Rochester, Minnesota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-004-1561-2

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-004-1561-2

HMG-CoA reductase inhibitors for the prevention of nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-004-1561-2

The cardiomyopathy of overload: an unnatural growth response in the hypertrophied heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-004-1561-2

Treatment of secondary hyperparathyroidism with vitamin D derivatives and calcimimetics before and after start of dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-004-1561-2

Folic Acid Reverts Dysfunction of Endothelial Nitric Oxide Synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-004-1561-2

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

12 December 2020

1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial

1 reference

12 December 2020

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

1 reference

12 December 2020

Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients

1 reference

12 December 2020

Cardiac disease in diabetic end-stage renal disease.

1 reference

12 December 2020

Short- and long-term mortality for patients undergoing primary angioplasty for acute myocardial infarction

1 reference

12 December 2020

Physical performance and associated electrolyte changes after haemoglobin normalization: a comparative study in haemodialysis patients

1 reference

12 December 2020

Poor long-term survival after acute myocardial infarction among patients on long-term dialysis

1 reference

12 December 2020

Decreased hematopoiesis in bone marrow of mice with congestive heart failure

1 reference

12 December 2020

Elevated serum concentration of cardiotoxic lipid peroxidation products in chronic renal failure in relation to severity of renal anemia.

1 reference

12 December 2020

Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Inf

1 reference

12 December 2020

Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial

1 reference

12 December 2020

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)

1 reference

12 December 2020

Collaborative overview of randomised trials of antiplatelet therapy--III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration

1 reference

12 December 2020

Effect of fluvastatin and dipyridamole on proteinuria and renal function in childhood IgA nephropathy with mild histological findings and moderate proteinuria.

1 reference

12 December 2020

Aldosterone and vascular damage

1 reference

12 December 2020

Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects

1 reference

12 December 2020

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

12 December 2020

Dyslipidemia management in adults with diabetes

1 reference

12 December 2020

Poor pre-dialysis glycaemic control is a predictor of mortality in type II diabetic patients on maintenance haemodialysis

1 reference

12 December 2020

The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction.

1 reference

12 December 2020

Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction

1 reference

12 December 2020

Long-term outcome of dialysis patients in the United States with coronary revascularization procedures

1 reference

12 December 2020

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

1 reference

12 December 2020

Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes

1 reference

12 December 2020

Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes

1 reference

12 December 2020

Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats

1 reference

12 December 2020

Recent intervention trials in hypertension initiated in Sweden--HOT, CAPPP and others. Hypertension Optimal Treatment Study. Captopril Prevention Project

1 reference

12 December 2020

Does oral folic acid lower total homocysteine levels and improve endothelial function in children with chronic renal failure?

1 reference

12 December 2020

Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Anemia in hemodialysis patients: variables affecting this outcome predictor.

1 reference

12 December 2020

Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis. Die Deutsche Diabetes Dialyse Studie Investigators

1 reference

12 December 2020

The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron

1 reference

12 December 2020

Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia

1 reference

12 December 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

12 December 2020

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

Tumor necrosis factor-alpha: a mediator of disease progression in the failing human heart

1 reference

12 December 2020

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

12 December 2020

Advances in the anemia of chronic disease

1 reference

12 December 2020

Cardiac hypertrophy and failure in hypertension

1 reference

12 December 2020

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

12 December 2020

Fluvastatin prevents nephropathy likely through suppression of connective tissue growth factor-mediated extracellular matrix accumulation

1 reference

12 December 2020

Effectiveness of aldosterone blockade in patients with diabetic nephropathy

1 reference

12 December 2020

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

12 December 2020

The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus

1 reference

12 December 2020

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

12 December 2020

Acute myocardial infarction in patients with end-stage renal disease

1 reference

12 December 2020

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

12 December 2020

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

1 reference

12 December 2020

Effects of haemoglobin normalization on quality of life and cardiovascular parameters in end-stage renal failure

1 reference

12 December 2020

The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease

1 reference

12 December 2020

Glycemic control is a predictor of survival for diabetic patients on hemodialysis

1 reference

12 December 2020

Aldosterone as a mediator of progressive renal dysfunction: evolving perspectives

1 reference

12 December 2020

10.1007/S11255-004-1561-2

Identifiers

DOI

1 reference

13 August 2017

1 reference